The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
08 2022
Historique:
received: 22 12 2021
revised: 16 05 2022
accepted: 18 05 2022
pubmed: 2 6 2022
medline: 20 7 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

To investigate the association of the lipidomic profile with osteoarthritis (OA) severity, considering the outcomes radiographic knee and hand OA, pain and function. We used baseline data from the Applied Public-Private Research enabling OsteoArthritis Clinical Headway (APPROACH) cohort, comprising persons with knee OA fulfilling the clinical American College of Rheumatology classification criteria. Radiographic knee and hand OA severity was quantified with Kellgren-Lawrence sum scores. Knee and hand pain and function were assessed with validated questionnaires. We quantified fasted plasma higher order lipids and oxylipins with liquid chromatography with tandem mass spectrometry (LC-MS/MS)-based platforms. Using penalised linear regression, we assessed the variance in OA severity explained by lipidomics, with adjustment for clinical covariates (age, sex, body mass index (BMI) and lipid lowering medication), measurement batch and clinical centre. In 216 participants (mean age 66 years, mean BMI 27.3 kg/m Within the APPROACH cohort lipidomics explained a minor portion of the variation in OA severity, which was most evident for the outcome hand pain. Our results suggest that eicosanoids may be involved in OA severity.

Identifiants

pubmed: 35644463
pii: S1063-4584(22)00749-X
doi: 10.1016/j.joca.2022.05.008
pii:
doi:

Substances chimiques

Oxylipins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1062-1069

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

M Loef (M)

Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.loef@lumc.nl.

L van de Stadt (L)

Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: l.a.van_de_stadt@lumc.nl.

S Böhringer (S)

Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: s.boehringer@lumc.nl.

A-C Bay-Jensen (AC)

Biomarkers and Research, Nordic Bioscience, Herlev, Denmark. Electronic address: acbj@nordicbio.com.

A Mobasheri (A)

Regenerative Medicine, State Research Institute Center of Innovative Medicine, Vilnius, Lithuania. Electronic address: Ali.Mobasheri@oulu.fi.

J Larkin (J)

GlaxoSmithKline USA, Philadelphia, PA, USA. Electronic address: jonathan.2.larkin@gsk.com.

F P J G Lafeber (FPJG)

Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, the Netherlands. Electronic address: F.Lafeber@umcutrecht.nl.

F J Blanco (FJ)

Servicio de Reumatologia, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain. Electronic address: Francisco.Blanco.Garcia@sergas.es.

I K Haugen (IK)

Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway. Electronic address: ida.k.haugen@gmail.com.

F Berenbaum (F)

Rheumatology, Sorbonne University, INSERM, AP-HP Saint-Antoine Hospital, Paris, France. Electronic address: francis.berenbaum@aphp.fr.

M Giera (M)

Center of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: M.A.Giera@lumc.nl.

A Ioan-Facsinay (A)

Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: AIF@genmab.com.

M Kloppenburg (M)

Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: g.kloppenburg@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH